eng Treatment outcomes of patients with BRCA-mutated, recurrent ovarian cancer in University Hospital Center Split
hrv Ishodi liječenja bolesnica s BRCA mutiranim recidivom karcinoma jajnika u Kliničkom bolničkom centru Split
Petrić-Miše, Branka; Pešo, Mirko; Hrepić, Darijo; Telesmanić-Dobrić, Vesna; Vrdoljak, Eduard
Libri Oncologici Vol. 50, No. 1, 2022
Aim: To evaluate the treatment outcomes, with emphasis on the efficacy and safety of olaparib, in patients with platinum-sensitive, BRCA-mutated, recurrent ovarian cancer treated at the University Hospital Center Split in the period from June 2016 to April 2021. Methods: Data were collected retrospectively from a medical history of 28 patients with platinum-sensitive, BRCAmutated, recurrent ovarian cancer. Medical records were reviewed for clinico-pathological characteristics, number of previous chemotherapy lines and platinum-free interval be...
Hrčak ID: 277743